Indeed, APOL1 is associated with an increased risk of CKD, including end-stage kidney disease (ESKD), focal segmental glomerulosclerosis (FSGS), and HIV-associated nephropathy (HIVAN), specifically in individuals with sub–Saharan African ancestry [6,7,8]. This evidence concerns the gene APOL1 and focal segmental glomerulosclerosis.